Searched for
BIOCON STAKE SALE
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...- Biocon shares jump 3% to hit new 52-week high on $4.5 billion Biologics IPO, merger reviewBiocon shares hit a new 52-week high after the company confirmed it is evaluating a potential merger of Biocon Biologics with the parent en...
- Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430Motilal Oswal Financial Services has recommended a buy on Biocon, targeting a price of Rs 430. The company, a leader in the pharmaceuticals...
- Stocks in news: Greaves Cotton, Biocon, Tata Motors, Hyundai, CiplaMarkets advanced nearly 1% last week, recording a two-week rally. Focus today includes Greaves Cotton's IPO plan for its subsidiary, Biocon...
- Biocon denies plans to sell $1.5 billion generic API businessBiocon API business: Biocon has refuted claims of considering the sale of its generic active pharmaceutical ingredient (API) business, valu...
- Buy Biocon, target price Rs 375: JM FinancialBiocon, incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 28934.46 Crore) operating in Pharmaceuticals secto...
- Biocon sells 10% stake in Syngene via open marketBiocon did not reveal the price at which the stake was sold.Officials at Syngene and Biocon did not immediately respond to a Reuters query ...
- Biocon Biologics to offer 15% stake to Serum Institute Life SciencesUnder the alliance, BBL will get committed access to 100 million doses of vaccines annually for 15 years and commercialisation rights of th...
- Add Biocon, target price Rs 453: Centrum BrokingBiocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 45078.00 Crore) operating in Pharmaceuticals ...
- True North set to buy 8-10% stake in Anthem for Rs 740 crTrue North will acquire about 8-10 per cent stake in Anthem Biosciences for Rs 740 crore ($75-100 million), at a valuation of $1 billion (R...
- Add Biocon, target price Rs 490: ICICI SecuritiesBiocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 54864.00 Crore) operating in Pharmaceuticals ...
- Buy Biocon, target price Rs 480: Motilal OswalBiocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 54366.00 Crore) operating in Pharmaceuticals ...
- Biocon shares gain 1% in early sessionShares of Biocon Ltd. traded 1.01 per cent up in trade at 11:03AM on Wednesday .
- Biocon sells 1.88% stake in Syngene for Rs 230 croreIn a separate filing, Syngene said Biocon has sold the shares for achieving minimum public shareholding requirement.
- Plan to list Syngene in August, use IPO proceeds for R&D: Kiran Mazumdar-ShawSyngene International, present in the contract services business, had filed its draft red herring prospectus (DRHP) with Sebi .
- Syngene gets FIPB nod to raise foreign investment to 44%Syngene, a subsidiary of Biocon, said it has received the Foreign Investment Promotion Board approval to raise foreign investment to 44 per...
- Biocon's arm Syngene International gets Sebi approval for IPOThe company plans to sell 22 mn equity shares, including reservation of up to two mn shares for Biocon shareholders.
- Biocon surges as company files prospectus for Syngene IPO to raise Rs 600 crore; ends in redBiocon surged over 3% in intraday trade on Thursday after the company filed prospectus for Syngene IPO on Wednesday to raise Rs 600 cr .
- Biocon Q3 Net dips 13% to Rs 91 crore; to offload 10-15% in SyngeneBio-pharmaceuticals contributed Rs 541 crore and research services Rs 220 crore to revenue for the reporting quarter.
- Biocon completes 10 per cent stake sale in SyngeneBiotechnology major Biocon today concluded sale of 10 per cent stake in its research arm Syngene for Rs 380 crore to IVF Trustee Company Pr...
Load More
